Laura Damme
Technik-/Wissenschafts-/F&E-Leiter bei TRANSMEDICS GROUP, INC.
Profil
Laura Damme is currently the Vice President-Clinical Affairs at TransMedics Group, Inc. Her former job was as the Director-United States & EMEA Clinical Studies at Thoratec Corp.
She completed her undergraduate degree at Grand Valley State University (Michigan) and her graduate degree at the University of Michigan.
Aktive Positionen von Laura Damme
Unternehmen | Position | Beginn |
---|---|---|
TRANSMEDICS GROUP, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2019 |
Ehemalige bekannte Positionen von Laura Damme
Unternehmen | Position | Ende |
---|---|---|
THORATEC CORPORATION | Corporate Officer/Principal | - |
Ausbildung von Laura Damme
Grand Valley State University (Michigan) | Undergraduate Degree |
University of Michigan | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
TRANSMEDICS GROUP, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Thoratec Corp.
Thoratec Corp. Medical SpecialtiesHealth Technology Thoratec Corp. develops, manufactures and markets proprietary medical devices used for circulatory support for the treatment of heart failure patients. The company's products include Ventricular Assist Devices, HeartMate Left Ventricular Assist System, HeartMate II Left Ventricular Assist System, Thoratec Paracorporeal Ventricular Assist Device and Thoratec Implantable Ventricular Assist. It also manufactures and markets the CentriMag Acute Circulatory System, HeartMate II, PVAD, IVAD and for pediatric patients PediMag/PediVAS Acute Circulatory System. Its ventricular assist devices products primarily serve patients suffering from late-stage heart failure. Heart Failure is a chronic disease that occurs when degeneration of the heart muscle reduces the pumping power of the heart, causing the heart to become too weak to pump blood at a level sufficient to meet the body's demands. The company operates its business through the Cardiovascular group segment, which develops, manufactures mechanical circulatory products to support the cardiovascular systems of humans and to provide product-related services. Thoratec was founded in March 1976 and is headquartered in Pleasanton, CA. | Health Technology |